In light of these recent reports demonstrating that PPARγ activation increases astrocytic GLT-1 expression in the context of ischemia and glioma cells, we showed that targeting PPARγ for GLT-1 modulation is also applicable in the context of HIV-1-associated brain inflammation. The gene discussed is PPARG; the disease is central nervous system cancer.